Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Development and Validation of a Comprehensive Work-Related Needs Measure.

Gallagher VC, Maher LP, Gallagher KP, Valle M.

Psychol Rep. 2017 Jan 1:33294117709259. doi: 10.1177/0033294117709259. [Epub ahead of print]

PMID:
28558545
3.

The therapeutic potential of novel anticoagulants.

Chi L, Rogers KL, Uprichard AC, Gallagher KP.

Expert Opin Investig Drugs. 1997 Nov;6(11):1591-605.

PMID:
15989566
4.

Studies on coronary arteriopathy in dogs following administration of CI-1020, an endothelin A receptor antagonist.

Albassam MA, Metz AL, Potoczak RE, Gallagher KP, Haleen S, Hallak H, McGuire EJ.

Toxicol Pathol. 2001 May-Jun;29(3):277-84.

PMID:
11442013
5.

Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran.

Chi L, Mertz TE, Rogers KL, Janiczek N, Peng YW, Saganek L, Bousley RF, Juneau PL, Uprichard AC, Gallagher KP.

J Thromb Thrombolysis. 2001 Feb;11(1):19-31.

PMID:
11248787
6.

Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog.

Ignasiak DP, McClanahan TB, Bousley RE, Juneau PL, Gallagher KP.

J Thromb Thrombolysis. 1998 Nov;6(3):199-206.

PMID:
10751802
7.

The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosis.

McClanahan TB, Hicks GW, Ignasiak DP, Bousley R, Mertz TE, Juneau P, Janiczek-Dolphin N, Kim IC, Gallagher KP.

J Thromb Thrombolysis. 2000 Dec;10(3):277-84.

PMID:
11122549
8.

Spontaneous thrombosis in mice carrying the factor V Leiden mutation.

Cui J, Eitzman DT, Westrick RJ, Christie PD, Xu ZJ, Yang AY, Purkayastha AA, Yang TL, Metz AL, Gallagher KP, Tyson JA, Rosenberg RD, Ginsburg D.

Blood. 2000 Dec 15;96(13):4222-6.

PMID:
11110695
9.

Chronic endothelin blockade in dogs with pacing-induced heart failure: possible modulation of sympathoexcitation.

McConnell PI, Olson CE, Patel KP, Blank DU, Olivari MT, Gallagher KP, Quenby-Brown E, Zucker IH.

J Card Fail. 2000 Mar;6(1):56-65.

PMID:
10746820
10.

Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosis.

McClanahan TB, Ignasiak DP, Juneau P, Finkle C, Winocour PD, Gallagher KP.

J Thromb Thrombolysis. 1999 Jun;7(3):301-6.

PMID:
10375391
11.

Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis.

Rogers KL, Chi L, Rapundalo ST, Kramer JB, Gallagher KP.

Basic Res Cardiol. 1999 Feb;94(1):15-22.

PMID:
10097826
12.

Impact of resting and ischemic blood flow on infarct probability in ischemic preconditioning--a new approach to infarct size-blood flow data by logistic regression.

Post H, Schulz R, Vahlhaus C, Hüsing J, Hirche H, Gallagher KP, Heusch G.

J Mol Cell Cardiol. 1998 Dec;30(12):2719-28.

PMID:
9990542
13.

A novel model of venous thrombosis in the vena cava of rabbits.

Chi L, Saganek LJ, Rogers KL, Mertz TE, Metz AL, Uprichard AC, Gallagher KP.

J Pharmacol Toxicol Methods. 1998 Jun;39(4):193-202.

PMID:
9845298
14.

Heat stress increases cardiac HSP72i but fails to reduce myocardial infarct size in rabbits 24 hours later.

Saganek LJ, Ignasiak DP, Batley BL, Potoczak RE, Dodd G, Gallagher KP.

Basic Res Cardiol. 1997 Oct;92(5):331-8.

PMID:
9486354
15.

Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size.

Martin BJ, McClanahan TB, Van Wylen DG, Gallagher KP.

Basic Res Cardiol. 1997 Aug;92(4):240-51. Erratum in: Basic Res Cardiol 1997 Dec;92(6):435.

PMID:
9342431
16.
17.

Effects of endothelin ETA receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits.

Ignasiak DP, McClanahan TB, Saganek LJ, Potoczak RE, Hallak H, Gallagher KP.

Eur J Pharmacol. 1997 Mar 5;321(3):295-300.

PMID:
9085040
18.

W(h)ither Myocardial Reperfusion Injury?

Gallagher KP.

J Thromb Thrombolysis. 1997 Jan;4(1):137-139. No abstract available.

19.

Effects of endothelin-receptor antagonism with PD156707 on myocardial stunning in swine.

McClanahan TB, Mertz TE, Ignasiak DP, Juneau PL, Gallagher KP.

J Cardiovasc Pharmacol. 1996 Nov;28(5):679-86.

PMID:
8945682
20.

Myocardial infarct size is smaller in dogs with pacing-induced heart failure.

Hoskins DE, Ignasiak DP, Saganek LJ, Gallagher KP, Peterson JT.

Cardiovasc Res. 1996 Aug;32(2):238-47.

PMID:
8796110
21.

Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.

Mertz TE, McClanahan TB, Flynn MA, Juneau P, Reynolds EE, Hallak H, Bradford L, Gallagher KP.

J Pharmacol Exp Ther. 1996 Jul;278(1):42-9.

PMID:
8764334
22.

Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.

Wang P, Gallagher KP, Downey JM, Cohen MV.

J Mol Cell Cardiol. 1996 Mar;28(3):579-88.

PMID:
9011641
23.

The regional effect of retrograde cardioplegia in areas of evolving ischemia.

Iannettoni MD, Rohs TJ Jr, Gallagher KP, Bolling SF.

Chest. 1995 Nov;108(5):1353-7.

PMID:
7587441
24.

Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.

McClanahan TB, Ignasiak DP, Martin BJ, Mertz TE, Gallagher KP.

Basic Res Cardiol. 1995 Mar-Apr;90(2):176-83.

PMID:
7646420
25.

Myocardial hibernation in terms of the flow-function relationship.

Gallagher KP.

Basic Res Cardiol. 1995 Jan-Feb;90(1):12-5. Review. No abstract available.

PMID:
7779047
26.

Tumor necrosis factor and interleukin-6 are not elevated in venous blood from ischemic canine myocardium.

Field G, Conn CA, McClanahan TB, Nao BS, Kluger MJ, Gallagher KP.

Proc Soc Exp Biol Med. 1994 Sep;206(4):384-91.

PMID:
8073047
27.

Stunning, preconditioning, and functional recovery after global myocardial ischemia.

Bolling SF, Olszanski DA, Childs KF, Gallagher KP, Ning XH.

Ann Thorac Surg. 1994 Sep;58(3):822-7.

PMID:
7944710
28.

Does adenosine deaminase inhibition protect ischemic myocardium?

Gallagher KP, McClanahan TB, Martin BJ, Saganek LJ, Ignasiak DP, Mertz TE, Van Wylen DG, Vinten-Johansen J.

Adv Exp Med Biol. 1994;370:291-4. Review. No abstract available.

PMID:
7660911
29.

Myocardial contractility in a canine model of the brain-dead organ donor.

Huber TS, Groh MA, Gallagher KP, D'Alecy LG.

Crit Care Med. 1993 Nov;21(11):1731-9.

PMID:
8222691
30.
31.

Flavone improves functional recovery after ischemia in isolated reperfused rabbit hearts.

Ning XH, Ding X, Childs KF, Bolling SF, Gallagher KP.

J Thorac Cardiovasc Surg. 1993 Mar;105(3):541-9.

PMID:
8445932
32.

The effect of intramyocardial pH on functional recovery in neonatal hearts receiving St. Thomas' Hospital cardioplegic solution during global ischemia.

Iannettoni MD, Bove EL, Fox MH, Groh MA, Bolling SF, Gallagher KP.

J Thorac Cardiovasc Surg. 1992 Aug;104(2):333-43.

PMID:
1495295
33.

Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty.

Muller DW, Topol EJ, Abrams GD, Gallagher KP, Ellis SG.

J Am Coll Cardiol. 1992 Aug;20(2):460-6.

34.

The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with fluorine-18-deoxyglucose.

Kalff V, Schwaiger M, Nguyen N, McClanahan TB, Gallagher KP.

J Nucl Med. 1992 Jul;33(7):1346-53.

35.

Acadesine (AICA-riboside) improves postischemic cardiac recovery.

Bolling SF, Groh MA, Mattson AM, Grinage RA, Gallagher KP.

Ann Thorac Surg. 1992 Jul;54(1):93-8.

PMID:
1610261
36.

Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model.

Siden R, Kadish A, Flowers W, Kutas L, Bieneman BK, DePietro J, Jenkins JP, Gallagher KP, Levy RJ.

J Cardiovasc Pharmacol. 1992 May;19(5):798-809.

PMID:
1381779
37.

Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat.

Lin H, Chensue SW, Strieter RM, Remick DG, Gallagher KP, Bolling SF, Kunkel SL.

J Heart Lung Transplant. 1992 Mar-Apr;11(2 Pt 1):330-5.

PMID:
1576139
38.

Effects of nontransmural ischemia on inner and outer wall thickening in the canine left ventricle.

Torry RJ, Myers JH, Adler AL, Liut CL, Gallagher KP.

Am Heart J. 1991 Nov;122(5):1292-9.

39.

Instantaneous hyperemic flow-versus-pressure slope index. Microsphere validation of an alternative to measures of coronary reserve.

Mancini GB, Cleary RM, DeBoe SF, Moore NB, Gallagher KP.

Circulation. 1991 Aug;84(2):862-70.

PMID:
1860227
40.

Local cyclosporine immunotherapy of heart transplants in rats enhances survival.

Bolling SF, Lin H, Annesley TM, Boyd JA, Gallagher KP, Levy RJ.

J Heart Lung Transplant. 1991 Jul-Aug;10(4):577-83.

PMID:
1911801
41.

ATP precursor depletion and postischemic myocardial recovery.

Bolling SF, Bove EL, Gallagher KP.

J Surg Res. 1991 Jun;50(6):629-33.

42.

Recovery of the neonatal heart after normothermic ischemia. Effect of oxygen and catalase.

Zweng TN, Lynch MJ, Bove EL, Fox MH, Iannettoni MD, Bolling SF, Gallagher KP.

J Thorac Cardiovasc Surg. 1991 Feb;101(2):326-36.

PMID:
1992243
43.

Hemodynamic alterations and regional myocardial blood flow during supraceliac aortic occlusion in dogs with a critical coronary stenosis.

Wahr JA, Gallagher KP, Tait AR, Hantler CB, Knight PR.

J Cardiothorac Vasc Anesth. 1991 Feb;5(1):3-9.

44.

Effects of ischemia on epicardial segment shortening.

Stirling MC, Choy M, McClanahan TB, Schott RJ, Gallagher KP.

J Surg Res. 1991 Jan;50(1):30-9.

45.

Hemodynamic effects of intraatrial administration of deferoxamine or deferoxamine-pentafraction conjugate to conscious dogs.

Forder JR, McClanahan TB, Gallagher KP, Hedlund BE, Hallaway PE, Shlafer M.

J Cardiovasc Pharmacol. 1990 Nov;16(5):742-9.

PMID:
1703595
46.

Determination of coronary flow reserve by parametric imaging.

Hess OM, McGillem MJ, DeBoe SF, Pinto IM, Gallagher KP, Mancini GB.

Circulation. 1990 Oct;82(4):1438-48.

PMID:
2144799
47.

The concentration of calcium in neonatal cardioplegia.

Zweng TN, Iannettoni MD, Bove EL, Pridjian AK, Fox MH, Bolling SF, Gallagher KP.

Ann Thorac Surg. 1990 Aug;50(2):262-7.

PMID:
2383114
48.

Myocardial protection with preconditioning.

Li GC, Vasquez JA, Gallagher KP, Lucchesi BR.

Circulation. 1990 Aug;82(2):609-19.

PMID:
2372907
49.

[Changes in systolic and diastolic function of reperfused myocardium after short coronary occlusions in conscious dogs].

Ning XH, He MX, Yuan F, McClanahan T, Gallagher KP.

Sheng Li Xue Bao. 1990 Aug;42(4):307-15. Chinese.

PMID:
2263954
50.

Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow.

Stewart RE, Schwaiger M, Hutchins GD, Chiao PC, Gallagher KP, Nguyen N, Petry NA, Rogers WL.

J Nucl Med. 1990 Jul;31(7):1183-90.

Supplemental Content

Loading ...
Support Center